Lyra Therapeutics Inc’s Market Journey: Closing Weak at 0.20, Down -4.08

The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.

The closing price of Lyra Therapeutics Inc (NASDAQ: LYRA) was $0.20 for the day, down -4.08% from the previous closing price of $0.21. In other words, the price has decreased by -$4.08 from its previous closing price. On the day, 0.6 million shares were traded.

Ratios:

Our analysis of LYRA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.64 and its Current Ratio is at 3.64. In the meantime, Its Debt-to-Equity ratio is 1.71 whereas as Long-Term Debt/Eq ratio is at 1.52.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on May 07, 2024, Downgraded its rating to Hold and sets its target price to $0.50 from $10 previously.

On May 07, 2024, H.C. Wainwright Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $12 to $2.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 8.79 while its Price-to-Book (P/B) ratio in mrq is 0.63.

Stock Price History:

Over the past 52 weeks, LYRA has reached a high of $6.79, while it has fallen to a 52-week low of $0.16. The 50-Day Moving Average of the stock is 1.95%, while the 200-Day Moving Average is calculated to be -34.51%.

Shares Statistics:

A total of 65.46M shares are outstanding, with a floating share count of 54.51M. Insiders hold about 16.73% of the company’s shares, while institutions hold 39.08% stake in the company.

Most Popular